FDA issues warning about counterfeit Ozempic after seizing ‘thousands’ of units

Thousands of counterfeit units of Ozempic have been seized by the U.S. Food and Drug Administration, which is now urging pharmacies, suppliers and patients to use caution when dealing with the drug. The FDA issued a warning Thursday about the counterfeits of Ozempic, a drug for type-2 diabetes that has also become popular for weight loss. Patients and practitioners are being advised to check the 1-milligram injectable product and not to use those labeled with lot number “NAR0074” and serial number “430834149057.” Five people have fallen ill from the counterfeit products, although none of them ...